Skip to main content
. 1999 Sep;117(3):425–429. doi: 10.1046/j.1365-2249.1999.01005.x

Fig. 3.

Fig. 3

Serum concentrations of soluble tumour necrosis factor receptor (sTNF-R) I and II and C-reactive protein (CRP) from 45 patients with advanced pancreatic cancer with no evidence of infection or jaundice 4 weeks after surgery or bile duct stenting presented by TNFB and TNF-308 genotype. Statistical analysis by Kruskal–Wallis test.